facebook twitter instagram linkedin google youtube vimeo tumblr yelp rss email podcast phone blog search brokercheck brokercheck Play Pause


A new wave of COVID-19 cases threatens to trip up the economy. Increasing cases in Europe and the United States have brought new restrictions on activities, but the market doesn’t appear to be fazed by the recent outbreaks. Progress on developing vaccines has provided a clear boost to sentiment, but prospects for a divided Congress and the potential for more fiscal policy support also may be playing a role.



Just as the economic recovery was beginning to gain some steam, COVID-19 cases have been rising dramatically in several regions around the world. The change of seasons is adding to concerns, as colder weather shifts more activities indoors increasing the chances of viral transmissions. This has prompted many governments to take greater action to try to curb the spread of COVID-19. Several countries and many states in the United States have rolled back reopening plans and implemented new restrictions such as school closures, nighttime curfews, and even stay-at-home orders.



Description automatically generated




 The new round of restrictions, dubbed “lockdown 2.0,” has already begun to cause a decline in economic activity in the Eurozone. Markit’s composite Purchasing Managers Index (PMI) for the Eurozone, a survey of purchasing managers’ spending plans released November 23, slipped back into contractionary (sub-50) territory at 45.1, dragged down by the services component. Manufacturing activity remained expansionary at 53.6—highlighting the outsized effects that the COVID-19 outbreak has had on service industries. 

While the United States has not implemented the same degree of restrictions as Europe, rising cases already have had an effect on consumer and business behavior. Restaurant-booking data from OpenTable has declined since mid-October, and weekly jobless claims have begun to tick higher—which will be key for consumer spending going forward. If cases continue to rise, we likely will see greater action by local governments to limit high-risk activities, which may further threaten the economic recovery. 

Meanwhile, we’ve received positive news on progress toward a vaccine in recent weeks as well as insight into the potential efficacy of the vaccine candidates. This will be key to propping up consumer confidence in the near term. However, the timeline for the actual rollout of the vaccine may take longer than many expect, even with the Food and Drug Administration’s Emergency Use Authorization expediting approval and distribution.



 With the end of the year rapidly approaching and stocks having exceeded our 2020 year-end fair value target of 3,450–3,500 for the S&P 500 Index, we are focusing on 2021. At this point, we believe the pandemic will recede over the course of 2021, which increases our confidence in a robust earnings recovery. Other factors supporting the potential for solid gains for stocks next year include a likely market-friendly split Congress (Democrats controlling the US House and Republicans in the majority in the Senate), prospects for additional fiscal stimulus over the next several months, and low interest rates.

For 2021 we maintain our equity overweight recommendation that we first put in place in March 2020. Although the latest wave of COVID-19 and lingering political uncertainty present risks to markets, we believe stocks are in the early stages of a new bull market, supported by a durable economic expansion. We maintain our slight preference for growth-style stocks over value style, but as the pandemic subsides and the economic outlook improves, cyclical value stocks may be poised for sustained outperformance. We would expect this environment to also be favorable for small cap stocks.


 Stocks may not appear fazed by the recent spike in COVID-19 cases in part because of expectations for more stimulus and prospects for vaccine distribution starting as soon as December. However, underlying economic data has begun to reflect the effects of efforts by governments and individuals to curb the spread of the virus. As we enter a challenging season, the battle against the virus continues. 

Everyone please stay safe and be well. Best wishes for an enjoyable holiday season! 

This material is for general information only and is not intended to provide specific advice or recommendations for any individual. There is no assurance that the views or strategies discussed are suitable for all investors or will yield positive outcomes. Investing involves risks including possible loss of principal. Any economic forecasts set forth may not develop as predicted and are subject to change. References to markets, asset classes, and sectors are generally regarding the corresponding market index. Indexes are unmanaged statistical composites and cannot be invested into directly. Index performance is not indicative of the performance of any investment and do not reflect fees, expenses, or sales charges. All performance referenced is historical and is no guarantee of future results. Any company names noted herein are for educational purposes only and not an indication of trading intent or a solicitation of their products or services. LPL Financial doesn’t provide research on individual equities.

©2021 Whalen Financial. All Rights Reserved